OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 1 filers reported holding OCULAR THERAPEUTIX INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,901 | -69.0% | 12,389 | -49.1% | 0.00% | – |
| Q2 2023 | $125,486 | -2.1% | 24,319 | 0.0% | 0.00% | – |
| Q1 2023 | $128,161 | +19318.3% | 24,319 | -89.6% | 0.00% | – |
| Q4 2022 | $660 | -99.9% | 234,783 | +60.7% | 0.00% | – |
| Q3 2022 | $607,000 | +39.9% | 146,122 | +35.5% | 0.00% | – |
| Q2 2022 | $434,000 | +422.9% | 107,812 | +544.7% | 0.00% | – |
| Q1 2022 | $83,000 | -29.1% | 16,723 | 0.0% | 0.00% | – |
| Q4 2021 | $117,000 | +234.3% | 16,723 | +46.4% | 0.00% | – |
| Q3 2019 | $35,000 | -30.0% | 11,423 | 0.0% | 0.00% | – |
| Q2 2019 | $50,000 | -47.4% | 11,423 | -52.1% | 0.00% | – |
| Q1 2019 | $95,000 | 0.0% | 23,831 | 0.0% | 0.00% | – |
| Q4 2018 | $95,000 | -52.5% | 23,831 | -18.1% | 0.00% | – |
| Q3 2018 | $200,000 | +13.0% | 29,090 | -26.7% | 0.00% | – |
| Q4 2017 | $177,000 | -27.8% | 39,664 | 0.0% | 0.00% | – |
| Q3 2017 | $245,000 | – | 39,664 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $31,590 | 100.00% |
| Opaleye Management Inc. | 5,780,000 | $29,824,800 | 7.13% |
| DELTEC ASSET MANAGEMENT LLC | 1,974,797 | $10,189,953 | 2.23% |
| Lynwood Capital Management Inc. | 262,500 | $1,354,500 | 1.72% |
| Endurant Capital Management LP | 368,438 | $1,901,140 | 1.66% |
| Knoll Capital Management, LLC | 200,000 | $1,032,000 | 1.25% |
| Knoll Capital Management, LLC | 95,800 | $814,300 | 0.99% |
| SECTORAL ASSET MANAGEMENT INC | 802,680 | $4,141,829 | 0.69% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,977 | $1,553,041 | 0.22% |
| Cormorant Asset Management, LP | 645,000 | $3,328,200 | 0.19% |